Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
MEDIROM Healthcare Technologies ( (MRM) ) has provided an update.
MEDIROM Healthcare Technologies’ subsidiary, MEDIROM MOTHER Labs, has successfully raised JPY260.3 million in its Series A financing round, reaching a pre-money valuation of JPY9 billion. The financing, led by NFES Technologies Inc. with participation from other prominent Japanese companies, underscores the growth potential and technological promise of MEDIROM MOTHER Labs. The company has recently received substantial orders for over 25,000 units of its innovative, recharge-free MOTHER Bracelet® from its B2B sales channels, highlighting its commercialization progress and the potential impact on sectors like healthcare and fitness.
More about MEDIROM Healthcare Technologies
MEDIROM MOTHER Labs Inc., a subsidiary of MEDIROM Healthcare Technologies Inc., operates in the health-tech sector, focusing on developing and selling the MOTHER Bracelet®, a recharge-free smart tracker, and offering health management solutions across various industries. The company aims to enhance health monitoring with its technology, targeting sectors such as caregiving, logistics, and manufacturing.
YTD Price Performance: -75.00%
Average Trading Volume: 154,098
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.06M
For an in-depth examination of MRM stock, go to TipRanks’ Stock Analysis page.
